Health

Results: 3973-3984 of 4421

Takeda Announces FY2023 H1 Results; Updates Full-Year Forecasts While Remaining on Track Towards Management Guidance

Roche collaborates with Ibex and Amazon Web Services to accelerate adoption of AI-enabled digital pathology solutions to help improve cancer diagnoses

Galderma Phase III Data Published in the New England Journal of Medicine: Full OLYMPIA 2 Trial Results Demonstrate Nemolizumab’s Rapid Onset of Action in Prurigo Nodularis Patients

New data from LEQEMBI® (lecanemab-irmb) phase 3 Clarity AD study and subcutaneous formulation presented at CTAD

PR Newswire associated0

Jazz Pharmaceuticals to Report 2023 Third Quarter Financial Results on November 8, 2023

Sangamo Therapeutics Announces Third Quarter 2023 Conference Call and Webcast

PR Newswire associated0

Qilu Pharmaceutical announces the latest results from its clinical study on QL1706, in combination with chemotherapy, as a first-line treatment for recurrent or metastatic cervical cancer

First Patient Dosed for MRCT Phase 3 Study on First-Line LS-SCLC of Henlius Anti-PD-1 mAb Serplulimab in Europe

PR Newswire associated0

Cumulus Neuroscience Presents Data at CTAD 2023 Annual Meeting

LivaNova to Present at the Stifel and Wolfe Healthcare Conferences

PR Newswire associated0

FDA Meeting Feedback Puts Turn Biotechnologies on Track to be First Longevity Company Taking Cell Rejuvenation Therapy to Clinic

PR Newswire associated0

NEWLY-LAUNCHED AMAZFIT ACTIVE AND AMAZFIT ACTIVE EDGE INTRODUCE A STYLISH WAY TO STAY ACTIVE & STAY HEALTHY